BLDR three-lens brief
Evidence-based stock research on BLDR. Three independent lenses — Quality, Momentum, Context — examine live data from SEC filings, the Federal Reserve, and market feeds. Every claim traces to its primary source.
Analyst mean target $118.10 — 31% above current (21 analysts). · Debt-to-equity of 117.2 — balance-sheet-heavy.
- Analyst mean target $118.10 — 31% above current (21 analysts).
- Debt-to-equity of 117.2 — balance-sheet-heavy.
BLDR closed at $90.04 (-0.11%) as of 2026-04-25. Market cap: $9.68B. P/E (trailing) 23.1. Positives: analyst mean target $118.10 — 31% above current (21 analysts).. Concerns: debt-to-equity of 117.2 — balance-sheet-heavy.. Last quarter: Revenue $3.36B, net income $31.50M, free cash flow $623.83M.
Why three lenses on BLDR, not one.
A single reasoning model has blind spots it doesn’t know about. We examine BLDRacross Quality (fundamentals), Momentum (price action and sentiment), and Context (macro/sector). Disagreement between lenses is surfaced, not hidden — it’s how you know when HOLD is the honest call.
Read the full methodologyDrop it in your newsletter or blog.
Free to embed. Updates every 6 hours. Links back to the full brief.
<iframe src="https://clearpathinvest.app/embed/BLDR" width="100%" height="420" frameborder="0" loading="lazy" title="ClearPath BLDR brief"></iframe>